Jung Chung-Ryong, Lahiji Shayan Fakhraei, Kim Youseong, Kim Hyeonjun, Jung Hyungil
Nanobiotechnology Laboratory, Building 123, Yonsei University, 50 Yonsei-ro, Seodaemun-gu, Seoul 03722, Korea.
Juvic Biotech, Inc., No. 208, Digital-ro 272, Guro-gu, Seoul 08389, Korea.
Pharmaceutics. 2020 Jun 23;12(6):581. doi: 10.3390/pharmaceutics12060581.
Dissolving microneedle (DMN) patches were developed as efficient and patient-friendly transdermal delivery systems for biopharmaceuticals. However, recent studies have confirmed that the efficiency of DMNs to deliver biopharmaceuticals is highly reduced because of incomplete insertion caused by the stiffness and elastic properties of the skin. Therefore, micropillar integrated DMNs were developed to overcome the insertion limitations of DMN patches. Although micropillars were designed as integrated applicators to implant DMNs across the skin, they can also become inserted into the skin, leading to skin injury and inflammation. Herein, we have developed a separable micropillar integrated DMN (SPDMN) capable of inserting DMNs across the skin with high efficiency while minimizing skin injury risk through the introduction of a safety ring feature. Unlike previously developed systems, the SPDMN does not require continuous skin attachment and can be detached immediately post-application, leaving DMNs implanted inside the skin. Altogether, the findings of this study lead to the development of a quick, safe, and efficient DMN-based drug delivery platform.
溶蚀性微针(DMN)贴片被开发为用于生物制药的高效且对患者友好的透皮给药系统。然而,最近的研究证实,由于皮肤的硬度和弹性特性导致微针不完全插入,DMN递送生物制药的效率大幅降低。因此,开发了微柱集成DMN以克服DMN贴片的插入限制。尽管微柱被设计为将DMN植入皮肤的集成施用器,但它们也可能会插入皮肤,导致皮肤损伤和炎症。在此,我们开发了一种可分离的微柱集成DMN(SPDMN),它能够高效地将DMN插入皮肤,同时通过引入安全环特征将皮肤损伤风险降至最低。与先前开发的系统不同,SPDMN不需要持续附着在皮肤上,并且在施用后可以立即分离,使DMN植入皮肤内部。总之,本研究的结果促成了一种快速、安全且高效的基于DMN的药物递送平台的开发。